NOS3 and myocardial infarction: Notably, EA has been shown to modulate endothelial function, promoting endothelial nitric oxide synthase (eNOS) activity and nitric oxide (NO) production, pivotal mediators of vasodilation and endothelial homeostasis, thereby counteracting endothelial dysfunction associated with MI-induced microvascular impairment (25, 26).